171 related articles for article (PubMed ID: 26626889)
21. Pharmacokinetic/pharmacodynamic evaluation of marbofloxacin as a single injection for Pasteurellaceae respiratory infections in cattle using population pharmacokinetics and Monte Carlo simulations.
Paulin A; Schneider M; Dron F; Woehrle F
J Vet Pharmacol Ther; 2018 Feb; 41(1):39-50. PubMed ID: 28542866
[TBL] [Abstract][Full Text] [Related]
22. The integrated use of pharmacokinetic and pharmacodynamic models for the definition of breakpoints.
Stass H; Dalhoff A
Infection; 2005 Dec; 33 Suppl 2():29-35. PubMed ID: 16518709
[TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetics and pharmacokinetic/pharmacodynamic evaluation of marbofloxacin against Coagulase-negative staphylococci, Staphylococcus aureus and Mycoplasma agalactiae pathogens in goats.
Serrano-Rodríguez JM; Fernández-Varón E; Rodríguez CMC; Andrés-Larrea MIS; Rubio-Langre S; de la Fe C; Dova SW; Bhardwaj P; Sidhu PK; Litterio NJ; Lorenzutti AM
Res Vet Sci; 2023 Jun; 159():1-10. PubMed ID: 37060837
[TBL] [Abstract][Full Text] [Related]
24. Comparative mutant prevention concentration and mechanism of resistance to veterinary fluoroquinolones in Staphylococcus pseudintermedius.
Awji EG; Tassew DD; Lee JS; Lee SJ; Choi MJ; Reza MA; Rhee MH; Kim TH; Park SC
Vet Dermatol; 2012 Aug; 23(4):376-80, e68-9. PubMed ID: 22409306
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida.
Potter T; Illambas J; Pelligand L; Rycroft A; Lees P
Vet J; 2013 Jan; 195(1):53-8. PubMed ID: 23084327
[TBL] [Abstract][Full Text] [Related]
26. Comparison of PK/PD Targets and Cutoff Values for Danofloxacin Against
Zhou YF; Sun Z; Wang RL; Li JG; Niu CY; Li XA; Feng YY; Sun J; Liu YH; Liao XP
Front Vet Sci; 2022; 9():811967. PubMed ID: 35187143
[TBL] [Abstract][Full Text] [Related]
27. Influence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model.
Kesteman AS; Ferran AA; Perrin-Guyomard A; Laurentie M; Sanders P; Toutain PL; Bousquet-Mélou A
Antimicrob Agents Chemother; 2009 Nov; 53(11):4740-8. PubMed ID: 19738020
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic-pharmacodynamic relationship of marbofloxacin for Escherichia coli and Pasturella multocida following repeated intramuscular administration in goats.
Bhardwaj P; Sidhu PK; Saini SPS; M B D; Rampal S
J Vet Pharmacol Ther; 2019 Jul; 42(4):430-439. PubMed ID: 31102281
[TBL] [Abstract][Full Text] [Related]
29. Determination of the pharmacokinetic-pharmacodynamic cut-off values of marbofloxacin in horses to support the establishment of a clinical breakpoint for antimicrobial susceptibility testing.
Bousquet-Mélou A; Schneider M; El Garch F; Broussou DC; Ferran AA; Lallemand EA; Triboulloy C; Damborg P; Toutain PL
Equine Vet J; 2021 Sep; 53(5):1047-1055. PubMed ID: 33169427
[TBL] [Abstract][Full Text] [Related]
30. Integrated pharmacokinetic-Pharmacodynamic (PK/PD) model to evaluate the in vivo antimicrobial activity of Marbofloxacin against Pasteurella multocida in piglets.
Zeng QL; Mei X; Su J; Li XH; Xiong WG; Lu Y; Zeng ZL
BMC Vet Res; 2017 Jun; 13(1):178. PubMed ID: 28619095
[TBL] [Abstract][Full Text] [Related]
31. Mutant-prevention concentration and mechanism of resistance in clinical isolates and enrofloxacin/marbofloxacin-selected mutants of Escherichia coli of canine origin.
Gebru E; Choi MJ; Lee SJ; Damte D; Park SC
J Med Microbiol; 2011 Oct; 60(Pt 10):1512-1522. PubMed ID: 21596912
[TBL] [Abstract][Full Text] [Related]
32. The Epidemiologic and Pharmacodynamic Cutoff Values of Tilmicosin against Haemophilus parasuis.
Zhang P; Hao H; Li J; Ahmad I; Cheng G; Chen D; Tao Y; Huang L; Wang Y; Dai M; Liu Z; Yuan Z
Front Microbiol; 2016; 7():385. PubMed ID: 27047487
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate.
Aliabadi FS; Lees P
J Vet Pharmacol Ther; 2002 Jun; 25(3):161-74. PubMed ID: 12081611
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin and PK/PD Modeling against
Lei Z; Liu Q; Xiong J; Yang B; Yang S; Zhu Q; Li K; Zhang S; Cao J; He Q
Front Pharmacol; 2017; 8():542. PubMed ID: 28871226
[TBL] [Abstract][Full Text] [Related]
35. [Pharmacodynamic and pharmacokinetic evaluation of respiratory fluoroquinolones. Guideline to selection of the most appropriate fluoroquinolone].
Parra-Ruiz J; Hernández-Quero J
Rev Esp Quimioter; 2012 Dec; 25(4):245-51. PubMed ID: 23303254
[TBL] [Abstract][Full Text] [Related]
36. Exploration of Clinical Breakpoint of Danofloxacin for
Xu Z; Huang A; Luo X; Zhang P; Huang L; Wang X; Mi K; Fang S; Huang X; Li J; Yuan Z; Hao H
Antibiotics (Basel); 2021 Jul; 10(7):. PubMed ID: 34356730
[No Abstract] [Full Text] [Related]
37. Antimicrobial susceptibility of Haemophilus parasuis isolates from Germany by use of a proposed standard method for harmonized testing.
Brogden S; Pavlović A; Tegeler R; Kaspar H; De Vaan N; Kehrenberg C
Vet Microbiol; 2018 Apr; 217():32-35. PubMed ID: 29615253
[TBL] [Abstract][Full Text] [Related]
38. PK-PD integration and modeling of marbofloxacin in sheep.
Sidhu PK; Landoni MF; Aliabadi FS; Lees P
Res Vet Sci; 2010 Feb; 88(1):134-41. PubMed ID: 19523661
[TBL] [Abstract][Full Text] [Related]
39. Mutant prevention concentration and phenotypic and molecular basis of fluoroquinolone resistance in clinical isolates and in vitro-selected mutants of Escherichia coli from dogs.
Gebru E; Damte D; Choi MJ; Lee SJ; Kim YH; Park SC
Vet Microbiol; 2012 Jan; 154(3-4):384-94. PubMed ID: 21893387
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic/pharmacodynamic relationship of marbofloxacin against Pasteurella multocida in a tissue-cage model in yellow cattle.
Shan Q; Wang J; Yang F; Ding H; Liang C; Lv Z; Li Z; Zeng Z
J Vet Pharmacol Ther; 2014 Jun; 37(3):222-30. PubMed ID: 24033339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
